Share-based Payment Arrangement, Expense of PROCEPT BioRobotics Corp from 30 Sep 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
PROCEPT BioRobotics Corp quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2020 to 30 Sep 2025.
  • PROCEPT BioRobotics Corp Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $14,490,000, a 70% increase year-over-year.
  • PROCEPT BioRobotics Corp Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $45,847,000, a 65% increase year-over-year.
  • PROCEPT BioRobotics Corp annual Share-based Payment Arrangement, Expense for 2024 was $31,840,000, a 66% increase from 2023.
  • PROCEPT BioRobotics Corp annual Share-based Payment Arrangement, Expense for 2023 was $19,134,000, a 85% increase from 2022.
  • PROCEPT BioRobotics Corp annual Share-based Payment Arrangement, Expense for 2022 was $10,337,000, a 172% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

PROCEPT BioRobotics Corp Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $45,847,000 $14,490,000 +$5,978,000 +70% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $39,869,000 $12,163,000 +$4,177,000 +52% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $35,692,000 $10,108,000 +$3,852,000 +62% 01 Jan 2025 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 $31,840,000 $9,086,000 +$4,106,000 +82% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
Q3 2024 $27,734,000 $8,512,000 +$3,186,000 +60% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $24,548,000 $7,986,000 +$2,882,000 +56% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $21,666,000 $6,256,000 +$2,532,000 +68% 01 Jan 2024 31 Mar 2024 10-Q 02 May 2025 2025 Q1
Q4 2023 $19,134,000 $4,980,000 +$2,096,000 +73% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $17,038,000 $5,326,000 +$2,101,000 +65% 01 Jul 2023 30 Sep 2023 10-Q 28 Oct 2024 2024 Q3
Q2 2023 $14,937,000 $5,104,000 +$2,428,000 +91% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024 2024 Q2
Q1 2023 $12,509,000 $3,724,000 +$2,172,000 +140% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q4 2022 $10,337,000 $2,884,000 +$1,388,000 +93% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $8,949,000 $3,225,000 +$2,300,000 +249% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $6,649,000 $2,676,000 +$1,951,000 +269% 01 Apr 2022 30 Jun 2022 10-Q 28 Jul 2023 2023 Q2
Q1 2022 $4,698,000 $1,552,000 +$902,000 +139% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $3,796,000 $1,496,000 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
Q3 2021 $925,000 +$362,000 +64% 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022 2022 Q3
Q2 2021 $725,000 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022 2022 Q2
Q1 2021 $650,000 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q3 2020 $563,000 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021 2021 Q3

PROCEPT BioRobotics Corp Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $31,840,000 +$12,706,000 +66% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
2023 $19,134,000 +$8,797,000 +85% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $10,337,000 +$6,541,000 +172% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $3,796,000 +$1,623,000 +75% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $2,173,000 01 Jan 2020 31 Dec 2020 10-K 22 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.